Double Blind, Phase I, Randomized, Parallel Group Study of Hip Decompression Compared to Hip Decompression Supplemented at the Point of Care With Adipose Derived Regenerative Cells for Bilateral Pre-Collapse Femoral Head Osteonecrosis

Trial Profile

Double Blind, Phase I, Randomized, Parallel Group Study of Hip Decompression Compared to Hip Decompression Supplemented at the Point of Care With Adipose Derived Regenerative Cells for Bilateral Pre-Collapse Femoral Head Osteonecrosis

Recruiting
Phase of Trial: Phase I

Latest Information Update: 11 Jan 2018

At a glance

  • Drugs ECCS 50 (Primary)
  • Indications Osteonecrosis
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Nov 2017 Status changed from not yet recruiting to recruiting.
    • 21 Nov 2017 New trial record
    • 13 Nov 2017 The U.S. FDA recently approved this trial, as reported in a Cytori Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top